Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$1.26 - $1.79 $378,000 - $537,000
-300,000 Reduced 93.02%
22,500 $38,000
Q3 2023

Nov 13, 2023

BUY
$1.61 - $2.54 $2,415 - $3,810
1,500 Added 0.47%
322,500 $584,000
Q4 2022

Feb 07, 2023

BUY
$1.63 - $3.52 $523,229 - $1.13 Million
321,000 New
321,000 $542,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Boston Family Office LLC Portfolio

Follow Boston Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.